Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells role of the p22^phox-containing NADPH oxidase

The heterodimeric transcription factor hypoxia-inducible factor-1 (HIF-1) is activated under hypoxic conditions, resulting in the upregulation of its target genes plasminogen activator inhibitor-1 (PAI-1) and vascular endothelial growth factor (VEGF). PAI-1 and VEGF are also induced in response to vascular injury, which is characterized by the activation of platelets and the coagulation cascade as well as the generation of reactive oxygen species (ROS). However, it is not known whether HIF-1 is also stimulated by thrombotic factors. We investigated the role of thrombin, platelet-associated growth factors, and ROS derived from the p22^phox-containing NADPH oxidase in the activation of HIF- 1 and the induction of its target genes PAI- 1 and VEGF in human vascular smooth muscle cells (VSMCs). Thrombin, platelet-derived growth factor-AB (PDGF-AB), and transforming growth factor-β₁ (TGF-β₁) upregulated HIF-1α protein in cultured and native VSMCs. This response was accompanied by nuclear accumulation of HIF-1α as well as by increased HIF-1 DNA-binding and reporter gene activity. The thrombin-induced expression of HIF-1α, PAI-1, and VEGF was attenuated by antioxidant treatment as well as by transfection of p22^phox antisense oligonucleotides. Inhibition of p38 mitogen-activated protein kinase and phosphatidylinositol-3-kinase significantly decreased thrombin-induced HIF-1α, PAI-1, and VEGF expression. These findings demonstrate that the HIF-1 signaling pathway can be stimulated by thrombin and platelet-associated growth factors and that a redox-sensitive cascade activated by ROS derived from the p22^phox-containing NADPH oxidase is crucially involved in this response.